metallic nanoparticles and in vitro cytotoxicity assessment

1
Abstracts / Toxicology Letters 196S (2010) S37–S351 S281 aggregation of NPs at higher concentration) showed no toxic- ity. doi:10.1016/j.toxlet.2010.03.1148 P303-028 Inhalation toxicity studies with 12 nanomaterials—Comparing effects and distribution in the lung R. Landsiedel, L. Ma-Hock, S. Treumann, V. Strauss, W. Wohlleben, K. Wiench, B.V. Ravenzwaay BASF SE, Germany Several studies demonstrate that identical mass concentrations of nanoparticles are more toxic to the lung than larger particles of similar chemistry. Surface area and particle count concentra- tion have been discussed as critical factor responsible for higher pulmonary toxicity of nanoparticles (Oberdoerster et al., 2000, Res. Rep. Health Eff. Inst. 96, 5–86, Stoeger et al., 2006, EHP 114, 328–333, Wittmaack, 2007, EHP 115, 187–194). We tested the toxicity of 15 substances (12 nanomaterials: SiO 2 , surface coated SiO 2 , TiO 2 P25, coated TiO 2 , CeO 2 , doted CeO 2 , ZrO 2 , BaSO 4 , carbon black, MWCNT1, MWCNT2 and – for comparison – 3-m-scaled materials: quartz, TiO 2 , and ZnO) after inhalation exposure. All materials were sufficiently characterized and tested by the well-established short-term inhalation toxicity protocol for nanomaterials (Ma-Hock et al., 2009, Inhal. Toxicol., 21, 102); total protein concentration and polymorphonuclear neutrophils in bron- choalveolar lavage fluide were used as sensitive indicators of effects in the lung. For the tested insoluble nanomaterials we did not see a translo- cation from the lung to other tissues but the draining lymph nodes, with the exception of coated silica, which was also detected in the spleen. The lung toxicity varied over two orders of magnitude (using mass concentration as dosimetry). And no single material property (chemical identity, size, shape, surface area, surface chem- istry) alone could be correlated to the toxic effect. We therefore conclude that nanomaterial’s toxicity is spanning a wide range and is different for different nanomaterials. Hence there is no gen- eral nanotoxicity but the toxicity of individual nanomaterials. To determine this toxicity testing is need (until a correlation of mate- rial properties with toxic effects has been established). This poster presents a short-term inhalation test for nanomaterials which was developed – and appears to be useful – in efficiently assessing nano- materials toxicity. doi:10.1016/j.toxlet.2010.03.1149 P303-029 Metallic nanoparticles and in vitro cytotoxicity assessment H. Parkkola, L. Vivero, M. Vega, M. Ramis, J. Querol, J. Sendra Endor Nanotechnologies, Spain Nanotechnology is a rapidly developing field of biomedical research. Among numerous nanomaterials there are wide differ- ences in properties and a growing need for understanding their effects on human health and environment. Biological activity of nanoparticles (NPs) depends on physicochemical characteristics (particle size and distribution, agglomeration state, shape, crystal structure, chemical composition, surface area, surface chemistry and surface charge and porosity) that are not routinely considered in toxicity screening tests. Our laboratory has used different cell viability assays to evaluate biocompatibility of different metallic nanoparticles. Mitochon- drial metabolism (MTT & WST-1 assays) and lysosomal membrane integrity (Neutral red) experiments showed differing results. We found that NPs can react with the components of some of these tests and interfere with the colorimetric assays. According to our data WST-1 was the most efficient assay to assess nanoparticle toxicity. We want to point out that in vitro techniques for toxicity eval- uation and their suitability for different NPs must be carefully considered to prevent false-positive or false-negative results. Stan- dardizing nanotoxicological assays in regard to the material used is highly substantial for achieving reproducible results. doi:10.1016/j.toxlet.2010.03.1150 P303-030 Toxicity studies of poly(anhydride) nanoparticles P. Ojer 1 , A. Lopez De Cerain 1 , P. Areses 2 , I. Pe ˜ nuelas 2 , J.M. Irache 1 1 University of Navarra, Spain, 2 Clínica Universidad de Navarra, Spain In recent years poly(anhydride) nanoparticles have successfully been developed as oral drug delivery systems, immunization or allergy treatment. Given that the obtained results have been rather promising, it is essential to evaluate their toxicity. In this context, conventional (NP), pegylated (PEG-NP) and cyclodextrin (HPCD- NP) nanoparticles were prepared by desolvation method, preserved by spray drying and characterized by studying size, zeta potential and morphology. Nanoparticles displayed a size of approximately 170 nm with negative surface charge. Cytotoxicity studies were developed by MTS and LDH assays in HepG2 cells; results showed that after 48 and 72 h incubation, significant cytotoxic effect was observed at the highest concentrations tested (1 and 2 mg/mL). In order to evaluate in vivo toxicity, single oral dose study was per- formed according to OCDE guideline 425 in female Wistar rats. Taking into account the results obtained, the LD50 for the for- mulations was found to be higher than 2.000 mg/kg bw. These findings coincide with biodistribution studies with nanoparticles labeled with 99mtechnetium. When nanoparticles were adminis- tered orally, they were located in the animals gut, with no evidence of distribution in other organs or nanoparticle translocation. In short, poly(anhydride) nanoparticles (NP, PEG-NP and HPCD-NP) did not show any toxic effects under the experimental conditions used in these studies. doi:10.1016/j.toxlet.2010.03.1151 P303-031 Difficulties encountered in the evaluation of the cytotoxicity of bare and coated gold nanoparticles by WST-1 and LDH A. Egizabal 1 , L. Goikoetxea 1 , N. Briz 1 , N. Alvarez 1 , L. Ballester 1 , J. Lorenzo 1 , J. Sendra 2 1 INASMET Tecnalia, France, 2 ENDOR Nanotechnologies, Spain Currently, nanoparticle in vitro cytotoxicity testing is based on methods established for hazard characterization of chemicals, as no nano-specific European standard exists. Many of these tests eval- uate the viability of the cells by using different indicator dyes to analyze the absorption/fluorescent emission.

Upload: h-parkkola

Post on 29-Oct-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Metallic nanoparticles and in vitro cytotoxicity assessment

etters

ai

d

PIe

RW

SootpR3

sB–ebnpci

cwt(picaedrpdm

d

PM

H

Nreen(sai

Abstracts / Toxicology L

ggregation of NPs at higher concentration) showed no toxic-ty.

oi:10.1016/j.toxlet.2010.03.1148

303-028nhalation toxicity studies with 12 nanomaterials—Comparingffects and distribution in the lung

. Landsiedel, L. Ma-Hock, S. Treumann, V. Strauss, W.ohlleben, K. Wiench, B.V. Ravenzwaay

BASF SE, Germany

everal studies demonstrate that identical mass concentrationsf nanoparticles are more toxic to the lung than larger particlesf similar chemistry. Surface area and particle count concentra-ion have been discussed as critical factor responsible for higherulmonary toxicity of nanoparticles (Oberdoerster et al., 2000,es. Rep. Health Eff. Inst. 96, 5–86, Stoeger et al., 2006, EHP 114,28–333, Wittmaack, 2007, EHP 115, 187–194).

We tested the toxicity of 15 substances (12 nanomaterials: SiO2,urface coated SiO2, TiO2 P25, coated TiO2, CeO2, doted CeO2, ZrO2,aSO4, carbon black, MWCNT1, MWCNT2 and – for comparison3-�m-scaled materials: quartz, TiO2, and ZnO) after inhalation

xposure. All materials were sufficiently characterized and testedy the well-established short-term inhalation toxicity protocol foranomaterials (Ma-Hock et al., 2009, Inhal. Toxicol., 21, 102); totalrotein concentration and polymorphonuclear neutrophils in bron-hoalveolar lavage fluide were used as sensitive indicators of effectsn the lung.

For the tested insoluble nanomaterials we did not see a translo-ation from the lung to other tissues but the draining lymph nodes,ith the exception of coated silica, which was also detected in

he spleen. The lung toxicity varied over two orders of magnitudeusing mass concentration as dosimetry). And no single materialroperty (chemical identity, size, shape, surface area, surface chem-

stry) alone could be correlated to the toxic effect. We thereforeonclude that nanomaterial’s toxicity is spanning a wide rangend is different for different nanomaterials. Hence there is no gen-ral nanotoxicity but the toxicity of individual nanomaterials. Toetermine this toxicity testing is need (until a correlation of mate-ial properties with toxic effects has been established). This posterresents a short-term inhalation test for nanomaterials which waseveloped – and appears to be useful – in efficiently assessing nano-aterials toxicity.

oi:10.1016/j.toxlet.2010.03.1149

303-029etallic nanoparticles and in vitro cytotoxicity assessment

. Parkkola, L. Vivero, M. Vega, M. Ramis, J. Querol, J. Sendra

Endor Nanotechnologies, Spain

anotechnology is a rapidly developing field of biomedicalesearch. Among numerous nanomaterials there are wide differ-nces in properties and a growing need for understanding theirffects on human health and environment. Biological activity of

anoparticles (NPs) depends on physicochemical characteristicsparticle size and distribution, agglomeration state, shape, crystaltructure, chemical composition, surface area, surface chemistrynd surface charge and porosity) that are not routinely consideredn toxicity screening tests.

196S (2010) S37–S351 S281

Our laboratory has used different cell viability assays to evaluatebiocompatibility of different metallic nanoparticles. Mitochon-drial metabolism (MTT & WST-1 assays) and lysosomal membraneintegrity (Neutral red) experiments showed differing results. Wefound that NPs can react with the components of some of these testsand interfere with the colorimetric assays. According to our dataWST-1 was the most efficient assay to assess nanoparticle toxicity.

We want to point out that in vitro techniques for toxicity eval-uation and their suitability for different NPs must be carefullyconsidered to prevent false-positive or false-negative results. Stan-dardizing nanotoxicological assays in regard to the material usedis highly substantial for achieving reproducible results.

doi:10.1016/j.toxlet.2010.03.1150

P303-030Toxicity studies of poly(anhydride) nanoparticles

P. Ojer 1, A. Lopez De Cerain 1, P. Areses 2, I. Penuelas 2, J.M.Irache 1

1 University of Navarra, Spain, 2 Clínica Universidad de Navarra,Spain

In recent years poly(anhydride) nanoparticles have successfullybeen developed as oral drug delivery systems, immunization orallergy treatment. Given that the obtained results have been ratherpromising, it is essential to evaluate their toxicity. In this context,conventional (NP), pegylated (PEG-NP) and cyclodextrin (HPCD-NP) nanoparticles were prepared by desolvation method, preservedby spray drying and characterized by studying size, zeta potentialand morphology. Nanoparticles displayed a size of approximately170 nm with negative surface charge. Cytotoxicity studies weredeveloped by MTS and LDH assays in HepG2 cells; results showedthat after 48 and 72 h incubation, significant cytotoxic effect wasobserved at the highest concentrations tested (1 and 2 mg/mL). Inorder to evaluate in vivo toxicity, single oral dose study was per-formed according to OCDE guideline 425 in female Wistar rats.Taking into account the results obtained, the LD50 for the for-mulations was found to be higher than 2.000 mg/kg bw. Thesefindings coincide with biodistribution studies with nanoparticleslabeled with 99mtechnetium. When nanoparticles were adminis-tered orally, they were located in the animals gut, with no evidenceof distribution in other organs or nanoparticle translocation. Inshort, poly(anhydride) nanoparticles (NP, PEG-NP and HPCD-NP)did not show any toxic effects under the experimental conditionsused in these studies.

doi:10.1016/j.toxlet.2010.03.1151

P303-031Difficulties encountered in the evaluation of the cytotoxicity ofbare and coated gold nanoparticles by WST-1 and LDH

A. Egizabal 1, L. Goikoetxea 1, N. Briz 1, N. Alvarez 1, L. Ballester 1, J.Lorenzo 1, J. Sendra 2

1 INASMET Tecnalia, France, 2 ENDOR Nanotechnologies, Spain

Currently, nanoparticle in vitro cytotoxicity testing is based on

methods established for hazard characterization of chemicals, as nonano-specific European standard exists. Many of these tests eval-uate the viability of the cells by using different indicator dyes toanalyze the absorption/fluorescent emission.